ARTICLE
23 September 2020

Drafting For Multiple Jurisdictions Miniseries: Part II - Data Considerations When Drafting

FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
Many patent owners are interested in trying to draft a single patent application that will serve them in several countries.
European Union Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Many patent owners are interested in trying to draft a single patent application that will serve them in several countries. This is ambitious, since there are many differences between various countries' patent systems, but perhaps not impossible. The patent drafter just needs to be aware of and try to balance all the different requirements in the single patent application. This series of articles will outline some important considerations when drafting a single patent application. In our first article (available here), we reviewed the grace period provisions in the U.S., Korea, China, and the European Patent Office ("EPO"). Since waiting for clinical trial data before filing a patent application is not necessarily advisable, in this article, we will look at how much data should be included on filing. The article may be found on Finnegan's AIA blog.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More